MTBP and B-cell non-Hodgkin lymphoma: In a separate analysis, Mtbp heterozygosity, like Mdm2 heterozygosity, delayed Myc-driven B cell lymphoma development in the Eμ-myc mouse model, which overexpresses Myc specifically in B cells.